PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease.
Saved in:
| Title: | PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease. |
|---|---|
| Authors: | Kannenkeril D; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Bosch A; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Kolwelter J; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.; Department of Cardiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany., Striepe K; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Berner L; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Pietschner R; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Ott C; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Schiffer M; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany., Achenbach S; Department of Cardiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany., Schmieder RE; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany. roland.schmieder@uk-erlangen.de. |
| Source: | Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2026 Feb; Vol. 115 (2), pp. 220-231. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Medizin Country of Publication: Germany NLM ID: 101264123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1861-0692 (Electronic) Linking ISSN: 18610684 NLM ISO Abbreviation: Clin Res Cardiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39565386 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kannenkeril+D%22">Kannenkeril D</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Bosch+A%22">Bosch A</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Kolwelter+J%22">Kolwelter J</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.; Department of Cardiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Striepe+K%22">Striepe K</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Berner+L%22">Berner L</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Pietschner+R%22">Pietschner R</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Ott+C%22">Ott C</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Schiffer+M%22">Schiffer M</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Achenbach+S%22">Achenbach S</searchLink>; Department of Cardiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Schmieder+RE%22">Schmieder RE</searchLink>; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Ulmenweg 18, 91054, Erlangen, Germany. roland.schmieder@uk-erlangen.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101264123%22">Clinical research in cardiology : official journal of the German Cardiac Society</searchLink> [Clin Res Cardiol] 2026 Feb; Vol. 115 (2), pp. 220-231. <i>Date of Electronic Publication: </i>2024 Nov 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Medizin%22">Springer Medizin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101264123 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1861-0692 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218610684%22">18610684 </searchLink><i>NLM ISO Abbreviation: </i>Clin Res Cardiol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39565386 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00392-024-02556-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 220 Titles: – TitleFull: PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kannenkeril D – PersonEntity: Name: NameFull: Bosch A – PersonEntity: Name: NameFull: Kolwelter J – PersonEntity: Name: NameFull: Striepe K – PersonEntity: Name: NameFull: Berner L – PersonEntity: Name: NameFull: Pietschner R – PersonEntity: Name: NameFull: Ott C – PersonEntity: Name: NameFull: Schiffer M – PersonEntity: Name: NameFull: Achenbach S – PersonEntity: Name: NameFull: Schmieder RE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1861-0692 Numbering: – Type: volume Value: 115 – Type: issue Value: 2 Titles: – TitleFull: Clinical research in cardiology : official journal of the German Cardiac Society Type: main |
| ResultId | 1 |